Therapeutic implications of circadian rhythms in cancer patients

Novartis Foundation Symposium

Volumn 227, Issue , 2000, Pages 119-142

  Lévi, Francis ^a  

^a HÔPITAL PAUL BROUSSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; CHRONOTHERAPY; CIRCADIAN RHYTHM; HUMAN; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; CHRONOTHERAPY; CIRCADIAN RHYTHM; HUMANS; NEOPLASMS;

EID: 0033643122     PISSN: None     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (50)

1. Benavides M 1991 Cancer avancé de l'ovaire: approche chronobiologique comme nouvelle stratégie du traitement et de la surveillance clinique et biologique. PhD thesis, Université Paris XI, Paris, France
2. Bertheault-Cvitkovic F, Jami A, Ithzaki M et al 1996 Biweekly intensified ambulatory chronomodulated chemotherapy with oxaliplatin, 5-fluorouracil and leucovorin in patients with metastatic colorectal cancer. J Clin Oncol 14:2950-2958
3. Bismuth H, Adam R, Lévi F et al 1996 Resection of initially unresectable liver metastases from colorectal cancer following systemic chemotherapy. Ann Surg 224:509-522
4. Bjarnason GA, Marsh R, Chu NM, Kerr 11998 Phase II study of 5-fluorouracil (FU) by a 14 day chronomodulated infusion in patients with metastatic colorectal cancer. Proc Am Soc Clin Oncol 17:275a
5. Bjarnason GA, Jordan RCK, Sothern RB 1999 Circadian variation in the expression of cell-cycle proteins in human oral epithelium. Am J Pathol 154:613-622
6. Brienza S, Lévi F, Valori VM et al 1993 Intensified (every 2 weeks) chronotherapy with 5-fluorouracil (5-FU), folinic acid (FA) and oxaliplatin (L-OHP) in previously treated patients with metastatic colorectal cancer. 29th Annual Meeting Am Soc Clin Oncol, Orlando, FL, USA, May 16-18. Proc Am Soc Clin Oncol 12:197 (abstr)
7. Buchi KN, Moore JG, Hrushesky WJM, Sothern RB, Rubin NH 1991 Circadian rhythm of cellular proliferation in the human rectal mucosa. Gastroenterology 101:410-415
8. Caussanel JP, Lévi F, Brienza S et al 1990 Phase I trial of 5-day continuous venous infusion of oxaliplatin at circadian rhythm-modulated rate compared with constant rate. J Natl Cancer Inst 82:1046-1050
9. Chollet Ph, Curé H, Garui C et al 1994 Phase II trial with chronomodulated 5-fluorouracil (5-FU) and folinic acid (FA) in metastatic colorectal cancer. Proceedings 6th International conference in Chronopharmacology and Chronotherapy, Amelia Island, FL, USA, July 5-9 1994, abstract VIIIb-4
10. Curé H, Adenis A, Tubiana-Mathieu N et al 1998 Phase II trial of chronomodulated (cm) high dose 5-fluorouracil (5-FU) and 1-folinic acid (1-FA) in patients with metastatic colorectal cancer (MCC). Proceedings 34th Annual Meeting Am Soc Clin Oncol, Los Angeles, CA, USA, May 16-19 1998, abstract 1048
11. Deprés-Brummer P, Metzger G, Lévi F 1998 Pharmacologic restoration of suppressed temperature rhythms in rats by melatonin, melatonin receptor agonist S20242 or 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). Eur J Pharmacol 347:57-66
12. Filipski E, Amat S, Lemaigre G, Vincenti M, Breillout F, Lévi F 1999 Relationship between circadian rhythm of vinorelbine toxicity and efficacy in p388-bearing mice. J Pharm Exp Ther 289:231-235
13. Garcia-Sainz M, Halberg F 1966 Mitotic rhythms in human cancer, reevaluated by electronic computer programs. Evidence for chronopathology. J Natl Cancer Inst 37:279-292
14. Garufi C, Lévi F, Aschelter AM et al 1997 A phase I trial of 5-day chronomodulated infusion of 5-fluorouracil and 1-folinic acid in patients with metastatic colorectal cancer. Eur J Cancer 33:1566-1571
15. Gautherie M, Gros C 1974 Circadian rhythm alteration of skin temperature in breast cancer. Chronobiologia 4:1-17
16. Giacchetti S, Zidani R, Perpoint B et al 1997 Phase III trial of 5-fluorouracil (5-FU), folinic acid (FA), with or without oxaliplatin (OXA) in previously untreated patients (pts) with metastatic colorectal cancer (MCC). Proceedings 33rd Annual Meeting Am Soc Clin Oncol May 17-20 Denver, CO, USA, abstract 805
17. Giacchetti S, Perpoint B, Zidani R et al for the International Organization of Cancer 1999a Phase III multicenter randomized trial of oxaliplatin addition to chronomodulated 5-fluorouracil-leucovorin as first line treatment of metastatic colorectal cancer. J Clin Oncol, in press
18. Giacchetti S, Itshaki M, Gruia G et al 1999b Long term survival of patients with unresectable colorectal liver metastases following infusional chemotherapy with 5-fluorouracil, folinic acid, oxaliplatin and surgery. Ann Oncol 10:1-7
19. Harris B, Song R, Soong S, Diasio RB 1990 Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion. Cancer Res 50:197-201
20. Hrushesky W 1985 Circadian timing of cancer chemotherapy. Science 228:73-75
21. Klein DC, Moore RY, Reppert SM 1991 Suprachiasmatic nucleus: the mind's clock. Oxford University Press, Oxford
22. Klevecz R, Braly P 1991 Circadian and ultradian cytokinetic rhythms of spontaneous human cancer. Ann NY Acad Sci 618:257-276
23. Klevecz R, Shymko R, Blumenfeld D, Braly P 1987 Circadian gating of S phase in human ovarian cancer. Cancer Res 47:6267-6271
24. Lévi F 1997 Chronopharmacology of anticancer agents. In: Redfern PH, Lemmer B (eds) Physiology and pharmacology of biological rhythms. Springer-Verlag, Berlin, p 299-331
25. Lévi F, Benavides M, Chevelle C et al 1990 Chemotherapy of advanced ovarian cancer with 4′-O-tetrahydropyranyl doxombicin (THP) and cisplatin: a phase II trial with an evaluation of circadian timing and dose intensity. J Clin Oncol 8:705-714
26. Lévi F, Misset JL, Brienza S et al 1992 A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer. Cancer 69:893-900
27. Lévi F, Perpoint B, Garufi C et al 1993 Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate. Eur J Cancer 29:1280-1284
28. Lévi F, Zidani R, Vannetzel JM et al 1994 Chronomodulated versus fixed infusion rate delivery of ambulatory chemotherapy with oxaliplatin, 5-fluorouracil and folinic acid in patients with colorectal cancer metastases. A randomized multiinstitutional trial. J Natl Cancer Inst 86:1608-1617
29. Lévi F, Soussan A, Adam R et al 1995 A Phase I-II trial of five-day continuous intravenous infusion of 5-fluorouracil delivered at circadian rhythm modulated rate in patients with metastatic colorectal cancer. J Infus Chemother 5:153-158
30. Lévi F, Zidani R, Misset JL 1997 Randomized multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy. Lancet 350:681-686
31. Lévi F, Zidani R, Brienza S et al 1999 A multicentre evaluation of intensified ambulatory chronomodulated chemotherapy with oxaliplatin, fluorouracil and leucovorin as initial treatment of patients with metastatic colorectal cancer. International Organization for Cancer Chronotherapy. Cancer 85:2532-2540
32. Li XM, Metzger G, Filipski E et al 1997 Pharmacologic modulation of reduced glutathione circadian rhythms by buthionine sulfoximine: relationship with cisplatin toxicity in mice. Toxicol Appl Pharmacol 143:281-290
33. Mansfield CM, Carabasi RA, Wells W, Borman K 1973 Circadian rhythm in the skin temperature of normal and cancerous breasts. Int J Chronobiol 1:235-243
34. Mormont C 1998 Sélection et validation d'un test prédictif de la survie des patients atteints de cancer colorectal métastasé, fondé sur l'altération du système circadien. PhD thesis, Université Paris XI, Paris, France
35. Mormont MC, Lévi F 1997 Circadian-system alterations during cancer processes: a review. Int J Cancer 70:241-247
36. Mormont MC, Bleuzen P, Lellouch J et al 1997 Prognostic value of circadian rhythm assessment for survival of patients with metastatic colorectal cancer. Proceedings of the 33rd Annual Meeting of the American Society of Clinical Oncology, Denver, CO, USA, May 17-20 1997, abstract 956
37. Mormont MC, Hecquet B, Bogdan A, Benavides M, Touitou Y, Lévi F 1998a Non-invasive estimation of the circadian rhythm in serum cortisol in patients with ovarian or colorectal cancer. Int J Cancer 78:421-424
38. Mormont MC, Giacchetti S, Waterhouse J et al 1998b Activity circadian rhythm as an independent prognostic factor of survival in patients (pts) with metastatic colorectal cancer (MCC). Proceedings of the 34th Annual Meeting of the American Society of Clinical Oncology, Los Angeles, CA, USA, May 16-19 1998, abstract 1032
39. Ohdo S, Makinosumi T, Ishizaki T et al 1997 Cell cycle-dependent chronotoxicity of irinotecan hydrochloride in mice. J Pharmacol Exp Ther 283:1383-1388
40. Smaaland R, Laerum OD, Lote K, Sletvold O, Sothern RB, Bjerknes R 1991 DNA synthesis in human bone marrow is circadian stage dependent. Blood 77:2603-2611
41. Smaaland R, Abrahamsen JF, Svardal AM, Lote K, Ueland PM 1992 DNA cell cycle distribution and glutathione (GSH) content according to circadian stage in bone marrow of cancer patients. Br J Cancer 66:39-45
42. Smaaland R, Lote K, Sothern RB, Laerum OD 1993 DNA synthesis and ploidy in non-Hodgkin's lymphomas demonstrate intrapatient variation depending on circadian stage of cell sampling. Cancer Res 53:3129-3138
43. Tahti E 1956 Studies of the effect of X-irradiation on 24 hour variations in the mitotic activity in human malignant tumors. Acta Path Microbiol Scand 177:1-61
44. Tampellini M, Filipski E, Liu X-H et al 1998 Docetaxel chronopharmacology in mice. Cancer Res 58:3896-3904
45. Touitou Y, Haus E 1992 Biological rhythms in clinical and laboratory medicine. Springer-Verlag, Berlin
46. Touitou Y, Lévi F, Bogdan A, Benavides M, Bailleul F, Misset JL 1995 Rhythm alteration in patients with metastatic breast cancer and prognostic factors. J Cancer Res Clin Oncol 121:181-188
47. Touitou Y, Bogdan A, Lévi F, Benavides M, Auzéby A 1996 Disruption of the circadian patterns of serum cortisol in breast and ovarian cancer patients: relationships with tumor marker antigens. Br J Cancer 74:1248-1252
48. Voutilainen A 1953 Uber di 24-stunden-rhythmik der mitozfrequenz in malignen tumoren. Acta Path Microbiol Scand (suppl) 99:1-104
49. Zagula-Mally ZW, Cardoso SS, Williams D et al 1979 Time point differences in skin mitotic activity of actinic keratoses and skin cancers. In: Reinberg A, Halberg F (eds) Chronopharmacology. Pergamon Press, New York, p 399-402
50. Zhang R, Lu Z, Liu T et al 1993 Relationship between circadian-dependent toxicity of 5-fluorodeoxyuridine and circadian rhythms of pyrimidine enzymes: possible relevance to fluoropyrimidine chemotherapy. Cancer Res 53:2816-2822